- In January 2025, Jubilant Ingrevia announced the commissioning of a new cGMP-compliant facility at Bharuch, Gujarat, with a capacity of 5,000 metric tonnes for manufacturing Niacinamide aimed at nutraceuticals, dietary active ingredients, and human consumption. This new unit is an extension of the company’s US FDA-approved plant that already exports to the U.S., Europe, Japan, and other global markets. The company plans to leverage this facility to expand into the global infant nutrition segment with food-grade niacin, in addition to strengthening its presence in skin and hair care applications
- In October 2022, NovaBay Pharmaceuticals announced the expansion of its DERMAdoctor Picture Porefect collection with the launch of the 15% Niacinamide Pore Minimizing Serum. The new high-potency formulation is designed to reduce the appearance of enlarged facial pores while delivering antioxidants and collagen-supporting agents to help address blackheads, discoloration, rough skin, acne, and excess oil
